Skip to content

BeauSaki Bird's Nest Peptide Efficacy

Efficacy Evaluation of BeauSaki Edible Bird's Best Peptide Product

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07723508
Enrollment
40
Registered
2026-07-23
Start date
2025-10-01
Completion date
2026-03-31
Last updated
2026-07-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Facial Skin Condition

Keywords

Skin Hydration, Skin Elasticity, Skin Brightness, Transepidermal Water Loss, Wrinkles, Skin Texture

Brief summary

The goal of this clinical trial is to learn whether BeauSaki Edible Bird's Nest Peptide Product can improve facial skin conditions in healthy adult participants. The main questions it aims to answer are: Can daily intake of the edible bird's nest peptide product improve facial skin hydration, elasticity, brightness, wrinkles, pores, spots, redness, and skin texture after 8 weeks? Is the edible bird's nest peptide product well tolerated by participants during the study period? Researchers will compare participants who take the edible bird's nest peptide capsule with participants who take a placebo capsule without edible bird's nest to see if the product improves facial skin conditions. Participants will: * Take one capsule daily for 8 weeks. * Visit the study site at baseline, week 4, and week 8 for non-invasive facial skin assessments. * Cleanse their face with water and rest under room temperature conditions for 30 minutes before each skin assessment. * Complete a brief questionnaire about perceived skin condition and product satisfaction at baseline, week 4, and week 8. * Have facial photographs taken for skin condition evaluation, with identifiable areas masked before disclosure.

Interventions

DIETARY_SUPPLEMENTBeauSaki Edible Bird's Nest Peptide Product

Participants will take one capsule daily for 8 weeks.

Participants will take one placebo capsule without edible bird's nest daily for 8 weeks.

Sponsors

Chia Nan University of Pharmacy & Science
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Participants aged over 18 years.

Exclusion criteria

* Individuals who are unwilling to participate voluntarily. * Individuals diagnosed by a physician with skin disease, liver cirrhosis, or chronic renal failure. * Individuals with known allergies to cosmetics, drugs, or foods. * Pregnant or breastfeeding individuals. * Individuals taking medications for chronic diseases. * Students taught by the principal investigator. * Individuals unwilling to allow their study-related photographs to be disclosed. Vegetarians.

Design outcomes

Primary

MeasureTime frameDescription
Facial Skin Analysis ParametersBaseline, week 4, and week 8VISIA Micro-Analysis Skin Image Analyzer was utilized to measure skin spots, wrinkles, texture, pores, UV spots, brown Spots, red areas, porphyrins. Units: arbitrary units. Facial skin condition will be assessed using non-invasive image-based facial skin analysis. Changes from baseline will be evaluated at week 4 and week 8.
Skin MoistureBaseline, week 4, and week 8Skin moisture meter (VapoMeter) was utilized to measure skin moisture. Units: g/m²h Facial skin condition will be assessed using non-invasive image-based facial skin analysis. Changes from baseline will be evaluated at week 4 and week 8.
Skin elasticityBaseline, week 4, and week 8Skin elastometer (Soft Plus) was utilized to measure skin elasticity. Units: arbitrary units. Facial skin condition will be assessed using non-invasive image-based facial skin analysis. Changes from baseline will be evaluated at week 4 and week 8.

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 24, 2026